Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 35, 2021 - Issue 8
176
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Identification and functional characterisation of Esculentin-2 HYba peptides and their C-terminally amidated analogs from the skin secretion of an endemic frog

, & ORCID Icon
Pages 1262-1266 | Received 03 May 2019, Accepted 13 Jul 2019, Published online: 22 Jul 2019
 

Abstract

Here, we report the identification, functional characterisation, and the effect of C-terminal amidation on the activity profile of two novel Esculentin-2 peptides (Esculentin-2 HYba1 and Esculentin-2 HYba2). The parent peptides and their analogs exhibited potent activity against the tested Gram-positive and Gram-negative bacteria. The effect of amidation was evident in the activity profile of fish pathogens and killing kinetics. The analogs showed a 10-fold decrease in MIC, and the killing time was reduced to 10–15 minutes. The hemolytic potential was unaltered upon amidation. The selectivity index revealed that these peptides are more selective to bacteria than mammalian cells. Cytotoxicity against Hep3B cells reveals their potential to destroy cancer cells; they showed potential inhibition compared to anticancer drug silymarin. The study also highlights the need for further truncations and modifications of esculentin peptides for developing them as lead drug molecules.

Graphical Abstract

Acknowledgements

We are grateful to Kerala Forest Department for sample collection permit. VK thanks KSCSTE for the fellowship.

Disclosure statement

No potential conflict of interest was reported by the authors

Additional information

Funding

This work was supported by a grant from Kerala State Council for Science, Technology, and Environment (KSCSTE), India (No.006/SRSLS/2011/CSTE).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.